WaferGen Bio-systems
WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The ICELL8 Single-Cell System is a first of its kind system that can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing. The system has demonstrated unbiased isolation of single cells from solid tumors, brain cells, pulmonary airway cells, and multiple cell lines. The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively parallel singleplex PCR for one-step target enrichment and library preparation for clinical NGS. The Apollo 324 system can be used to process DNA and RNA from clinical samples to next generation sequencing ready libraries. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries.
About WaferGen Bio-systems
Founded
2003Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$56MCategory
Industry
BiotechnologyLocation
City
FremontState
CaliforniaCountry
United StatesWaferGen Bio-systems
Find your buyer within WaferGen Bio-systems